Flexion Therapeutics Inc (FLXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Flexion Therapeutics Inc (FLXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH194959D
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Flexion Therapeutics Inc (Flexion) develops and commercializes pain therapies. The company's pipeline is focused on indications that includes osteoarthritis knee pain (repeat administration), osteoarthritis knee synovial inflammation, bilateral knee osteoarthritis pain shoulder and hip osteoarthritis pain and inflammatory conditions. The company's marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients confronting osteoarthritis-related knee pain. Flexion employs its proprietary microsphere technology to combine TA with a PLGA matrix for formulating Zilretta. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US.

Flexion Therapeutics Inc (FLXN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Flexion Therapeutics Raises USD 20 Million In Series B Financing 11

Flexion Therapeutics Raises Additional USD 13 Million In Series A Financing 13

Licensing Agreements 14

Flexion Therapeutics to Acquire Rights to GQ-203 14

Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 15

Equity Offering 16

Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 16

Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 18

Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 20

Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 22

Flexion Therapeutics Completes IPO For USD 74.7 Million 24

Debt Offering 26

Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 26

Acquisition 27

Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 27

Flexion Therapeutics Inc-Key Competitors 28

Flexion Therapeutics Inc-Key Employees 29

Flexion Therapeutics Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Aug 07, 2018: Flexion Therapeutics reports second-quarter 2018 financial results and recent business highlights 31

May 08, 2018: Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights 33

Mar 08, 2018: Flexion Therapeutics Reports Full Year 2017 Financial Results 35

Nov 06, 2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights 36

Aug 08, 2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights 37

May 04, 2017: Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights 38

Mar 09, 2017: Flexion Reports Year-End 2016 Financial Results 39

Corporate Communications 40

May 07, 2018: Flexion Therapeutics Appoints David Arkowitz As Chief Financial Officer 40

Dec 12, 2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as CMO 41

Dec 11, 2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer 42

Jun 28, 2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary 43

Apr 07, 2017: Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer 44

Product News 45

07/10/2017: Flexion Therapeutics: Update on FX101 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

List of Tables

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Flexion Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Flexion Therapeutics Raises USD 20 Million In Series B Financing 11

Flexion Therapeutics Raises Additional USD 13 Million In Series A Financing 13

Flexion Therapeutics to Acquire Rights to GQ-203 14

Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 15

Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 16

Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 18

Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 20

Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 22

Flexion Therapeutics Completes IPO For USD 74.7 Million 24

Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 26

Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 27

Flexion Therapeutics Inc, Key Competitors 28

Flexion Therapeutics Inc, Key Employees 29

Flexion Therapeutics Inc, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Flexion Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18358
Site License
USD 500 INR 36715
Corporate User License
USD 750 INR 55073

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com